Michel Ferrari | Academic Influence

Michel Ferrari's AcademicInfluence.com Rankings

Michel Ferrari

Medical

#620

World Rank

#829

Historical Rank

Neurology

#57

World Rank

#100

Historical Rank

medical Degrees

Download Badge

Medical

Michel Ferrari's Degrees

Doctorate Medicine University of Geneva
PhD Neuroscience University of Zurich

Why Is Michel Ferrari Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michel D. Ferrari is a Swiss neurologist and professor of neurology at Leiden University and Leiden University Medical Center. He was a winner of the 2009 Spinoza Prize. He is considered to be the foremost migraine expert of the Netherlands, as well as one of the six top scientist in the field worldwide.

(See a Problem?)

Michel Ferrari's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 (1996) (2260)
Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4 (1996) (2260)
Migraine--current understanding and treatment. (2002) (1752)
European Position Paper on Rhinosinusitis and Nasal Polyps 2020. (2020) (1562)
Analysis of shared heritability in common disorders of the brain (2016) (1385)
Coding of facial expressions of pain in the laboratory mouse (2010) (1010)
Migraine as a risk factor for subclinical brain lesions. (2004) (949)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials (2001) (874)
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine (2005) (796)
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition (2000) (643)
A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression (2004) (633)
Erratum: Detection and interpretation of shared genetic influences on 42 human traits (2016) (417)
The prevalence and characteristics of migraine in a population-based cohort (1999) (402)
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. (2005) (377)
Genome-wide association study reveals three susceptibility loci for common migraine in the general population (2011) (361)
Novel mutations in the Na+, K+‐ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions (2003) (360)
C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy (2007) (356)
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1 (2010) (350)
Ergotamine in the acute treatment of migraine: a review and European consensus. (2000) (343)
The impact of migraine on quality of life in the general population (2000) (341)
Genome-wide meta-analysis identifies new susceptibility loci for migraine (2013) (336)
Delayed cerebral edema and fatal coma after minor head trauma: Role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine (2001) (333)
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood (2012) (329)
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood (2012) (329)
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study (2010) (326)
The origin of the major cystic fibrosis mutation (ΔF508) in European populations (1994) (321)
Coronary side-effect potential of current and prospective antimigraine drugs. (1998) (311)
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. (2008) (302)
Enhanced Excitatory Transmission at Cortical Synapses as the Basis for Facilitated Spreading Depression in CaV2.1 Knockin Migraine Mice (2009) (302)
Migraine pathophysiology: lessons from mouse models and human genetics (2015) (300)
Cardiovascular risk factors and migraine (2005) (295)
Molecular genetics of migraine (2009) (288)
Genome-wide association analysis identifies susceptibility loci for migraine without aura (2012) (286)
Serotonin metabolism in migraine (1989) (264)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study (2018) (258)
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. (2008) (255)
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. (2014) (227)
Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group (2017) (219)
Migraine and MTHFR C677T genotype in a population‐based sample (2006) (218)
On Serotonin and Migraine: A Clinical and Pharmacological Review (1993) (216)
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia (1999) (214)
Attack Frequency and Disease Duration as Indicators for Brain Damage in Migraine (2008) (211)
High cortical spreading depression susceptibility and migraine‐associated symptoms in Cav2.1 S218L mice (2010) (202)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults (2018) (196)
Structural brain changes in migraine. (2012) (196)
Cerebral microbleeds in CADASIL (2001) (185)
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial (2019) (179)
Cutaneous allodynia as a predictor of migraine chronification. (2013) (175)
Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. (2007) (170)
Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. (1993) (170)
Analysis of risk factors for the development of liver disease associated with cystic fibrosis. (1994) (169)
Genetic heterogeneity of familial hemiplegic migraine. (1994) (164)
Neuroexcitatory plasma amino acids are elevated in migraine (1990) (164)
Wiping Out CGRP: Potential Cardiovascular Risks. (2016) (157)
The Prevalence of Premonitory Symptoms in Migraine: A Questionnaire Study in 461 Patients (2006) (156)
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. (1996) (154)
Migraine Mutations Increase Stroke Vulnerability by Facilitating Ischemic Depolarizations (2012) (152)
Brain Stem and Cerebellar Hyperintense Lesions in Migraine (2006) (152)
Iron Accumulation in Deep Brain Nuclei in Migraine: A Population-Based Magnetic Resonance Imaging Study (2009) (151)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial (2001) (151)
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial (2010) (150)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages--3rd-6th decades. (2003) (148)
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study (2017) (141)
5-HT(1)-like receptor agonists and the pathophysiology of migraine. (1989) (139)
Frontal lobe structure and executive function in migraine patients (2008) (139)
Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine (1998) (138)
Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study. (2009) (135)
Migraine: gene mutations and functional consequences (2007) (135)
Intranasal sumatriptan in cluster headache (2003) (134)
Eletriptan in acute migraine (2000) (128)
Chronic Frequent Headache in the General Population: Prevalence and Associated Factors (2006) (128)
Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks (1996) (127)
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition (2019) (127)
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. (2001) (127)
Features involved in the diagnostic delay of cluster headache (2003) (125)
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence (2020) (123)
Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. (2009) (123)
Genetic heterogeneity in Italian families with familial hemiplegic migraine (1999) (123)
Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura (1995) (123)
Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. (1998) (122)
Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation (2004) (121)
Phenotypic clustering of lamin A/C mutations in neuromuscular patients (2007) (119)
Enhanced Subcortical Spreading Depression in Familial Hemiplegic Migraine Type 1 Mutant Mice (2011) (116)
Clinical and experimental effects of sumatriptan in humans. (1993) (114)
Divergent sodium channel defects in familial hemiplegic migraine (2008) (113)
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3) (2002) (113)
Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine (2007) (108)
Double-gradient DGGE for optimized detection of DNA point mutations. (1997) (108)
Lacunar Infarcts Are the Main Correlate With Cognitive Dysfunction in CADASIL (2007) (108)
Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache Recurrences (1994) (106)
The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies (2007) (106)
Interictal cortical hyperexcitability in migraine patients demonstrated with transcranial magnetic stimulation (1996) (105)
Migraine. Identifying and removing barriers to care. (1994) (104)
A high-density association screen of 155 ion transport genes for involvement with common migraine. (2008) (102)
Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. (2003) (100)
Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice (2009) (99)
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. (2016) (99)
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine (2015) (98)
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine (2015) (98)
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. (2000) (98)
Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis (2017) (98)
Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of the Cortical Spreading Depression Inhibiting Agent Tonabersat in Migraine Prophylaxis (2009) (95)
Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities (2018) (95)
Risk Factors for Headache Recurrence After Sumatriptan: A Study in 366 Migraine Patients (1996) (95)
Shared genetic factors in migraine and depression (2010) (94)
Hypoxia-Induced Acute Mountain Sickness is Associated with Intracellular Cerebral Edema: A 3 T Magnetic Resonance Imaging Study (2008) (93)
No acute antimigraine efficacy of CP‐122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double‐blind, placebo‐controlled clinical trials (2000) (92)
European headache federation consensus on technical investigation for primary headache disorders (2015) (92)
Epigenetic mechanisms in migraine: a promising avenue? (2013) (91)
Sumatriptan in clinical practice (1996) (90)
Shared genetic basis for migraine and ischemic stroke (2015) (89)
MRI correlates of cognitive decline in CADASIL (2009) (89)
Meta-analysis of genome-wide association for migraine in six population-based European cohorts (2011) (89)
Cortical excitability and response variability of transcranial magnetic stimulation. (1996) (88)
Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation (2009) (87)
Unbalanced Randomization Influences Placebo Response: Scientific Versus Ethical Issues Around the Use of Placebo in Migraine Trials (1999) (86)
First Mutation in the Voltage-Gated Nav1.1 Subunit Gene SCN1A with Co-Occurring Familial Hemiplegic Migraine and Epilepsy (2009) (81)
Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation (2006) (81)
5‐HT1 receptors in migraine pathophysiology and treatment (1995) (80)
Cerebellar Ataxia by Enhanced CaV2.1 Currents Is Alleviated by Ca2+-Dependent K+-Channel Activators in Cacna1aS218L Mutant Mice (2012) (79)
Familial Hemiplegic Migraine: A Clinical Comparison of Families Linked and Unlinked to Chromosome 19 (1996) (79)
Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. (2002) (79)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine (2016) (79)
Unexplained neonatal respiratory distress due to congenital surfactant deficiency. (2007) (78)
The Economic Burden of Migraine to Society (1998) (76)
Inhibition of the P2X7–PANX1 complex suppresses spreading depolarization and neuroinflammation (2017) (76)
Fetal DNA detection in maternal plasma throughout gestation (2005) (75)
Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency (1996) (75)
Voxel-based morphometry in hypocretin-deficient narcolepsy. (2002) (75)
Double-Blind, Placebo-Controlled, Dose-Finding Study of Rizatriptan (MK-462) in the Acute Treatment of Migraine (1997) (74)
Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. (1998) (74)
TNFα Levels and Macrophages Expression Reflect an Inflammatory Potential of Trigeminal Ganglia in a Mouse Model of Familial Hemiplegic Migraine (2013) (74)
The hypothalamus in episodic brain disorders (2002) (73)
Slowing Down of Recovery as Generic Risk Marker for Acute Severity Transitions in Chronic Diseases (2016) (73)
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment (2019) (73)
Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine (1997) (73)
Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. (1988) (73)
Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine (2006) (72)
Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy (2005) (72)
Familial and Sporadic Hemiplegic Migraine: Diagnosis and Treatment (2013) (72)
Cerebral Hemodynamics and White Matter Hyperintensities in CADASIL (2003) (72)
Are Migraineurs at Increased Risk of Adverse Drug Responses?: A Meta‐Analytic Comparison of Topiramate‐Related Adverse Drug Reactions in Epilepsy and Migraine (2009) (71)
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: Rationale and protocol of a randomised trial (2013) (71)
Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice (2013) (71)
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks (1992) (70)
Evaluation of diagnostic NOTCH3 immunostaining in CADASIL (2003) (70)
Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study (2000) (69)
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults (2020) (69)
Is Familial Hemiplegic Migraine a Hereditary form of Basilar Migraine? (1995) (69)
What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients (2014) (69)
Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms (2011) (69)
Genetic and clinical heterogeneity of ferroportin disease (2005) (68)
Neuroimaging in trigeminal autonomic cephalgias: when, how, and of what? (2009) (68)
Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study. (1992) (68)
Quantitative Analysis of Fetal DNA in Maternal Plasma in Pathological Conditions Associated with Placental Abnormalities (2001) (67)
Migraine and Genetic and Acquired Vasculopathies (2009) (66)
Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration (2016) (66)
Familial hemiplegic migraine CaV2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain (2010) (65)
Cortical glutamate in migraine (2017) (65)
5‐HT1B Receptor Polymorphism and Clinical Response to Sumatriptan (1998) (65)
Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. (1995) (65)
Genetic analysis for a shared biological basis between migraine and coronary artery disease (2015) (64)
From migraine genes to mechanisms (2015) (64)
Migraine in The Elderly: A Review (2007) (64)
Genome-wide association study of migraine implicates a common susceptibility variant on 8 q 22 . 1 (2010) (64)
Migraine in the Triptan Era: Lessons From Epidemiology, Pathophysiology, and Clinical Science (2009) (63)
Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution (1997) (63)
Brainstem spreading depolarization and cortical dynamics during fatal seizures in Cacna1a S218L mice (2019) (62)
How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence. (1999) (62)
Myocardial Infarction in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) (2003) (62)
Genetics of migraine. (1997) (62)
P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy. (1998) (62)
Detection of point mutations by capillary electrophoresis in liquid polymers in temporal thermal gradients (1994) (61)
A Review of the Genetic Relation Between Migraine and Epilepsy (2008) (60)
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance. (2009) (60)
No evidence of fetal DNA persistence in maternal plasma after pregnancy (2003) (60)
Recent findings in headache genetics (2004) (60)
Acetazolamide treatment for migraine aura status (2000) (60)
Normobaric Hypoxia and Nitroglycerin as Trigger Factors for Migraine (2006) (59)
Migraine is not associated with enhanced atherosclerosis (2013) (59)
Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice (2017) (58)
Mutation Analysis of the CACNA1A Calcium Channel Subunit Gene in 27 Patients With Sporadic Hemiplegic Migraine (2002) (58)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine (2011) (58)
Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification (2013) (58)
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization. (2011) (58)
Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial (2019) (58)
CACNA1A Mutation Linking Hemiplegic Migraine and Alternating Hemiplegia of Childhood (2008) (58)
Mutational scanning of the ABCR gene with double-gradient denaturing-gradient gel electrophoresis (DG-DGGE) in Italian Stargardt disease patients (2001) (57)
Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs (2011) (57)
Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases. (2011) (57)
Migraine genetics: An update (2005) (56)
Basic fibroblast growth factor and its receptor messenger ribonucleic acids are expressed in human ovarian epithelial neoplasms. (1993) (56)
Cerebral small vessel disease genomics and its implications across the lifespan (2020) (56)
Chronic Frequent Headache in the General Population: Comorbidity and Quality of Life (2006) (56)
Partial Cosegregation of Familial Hemiplegic Migraine and a Benign Familial Infantile Epileptic Syndrome (1997) (56)
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome (2010) (55)
Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. (2002) (54)
Chronotypes and circadian timing in migraine (2017) (54)
Meta-Analysis of Rizatriptan Efficacy in Randomized Controlled Clinical Trials (2001) (54)
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial (2019) (53)
Gene dosage-dependent transmitter release changes at neuromuscular synapses of Cacna1a R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness (2005) (53)
CADASIL and migraine: A narrative review (2010) (52)
Migraine (2022) (52)
Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care (2013) (51)
IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2 (2020) (51)
Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. (2004) (50)
Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families (2018) (50)
Lack of Asymmetry of Middle Cerebral Artery Blood Velocity in Unilateral Migraine (1993) (50)
Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a‐mutant mouse rolling Nagoya (2007) (50)
Cluster headache and the hypocretin receptor 2 reconsidered: A genetic association study and meta-analysis (2015) (50)
Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study. (2015) (50)
Chronic Daily Headache in Children and Adolescents (1994) (50)
What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study (2014) (50)
Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. (2016) (50)
Syncope in migraine (2006) (50)
Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice (2020) (49)
Genetic Biomarkers for Migraine (2006) (49)
Sumatriptan ‐ Nonresponders: A Survey in 366 Migraine Patients (1996) (49)
Cluster headache in women: relation with menstruation, use of oral contraceptives, pregnancy, and menopause (2006) (49)
Structural and functional brain signatures of C9orf72 in motor neuron disease (2017) (48)
Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. (1991) (48)
Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane (1996) (48)
Genotype-phenotype correlation in cystic fibrosis patients. (1996) (48)
Familial hemiplegic migraine in the Netherlands (1994) (48)
Genetic models of migraine. (2007) (48)
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition (2018) (48)
Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis. (2010) (47)
TREX1 gene variant in neuropsychiatric systemic lupus erythematosus (2009) (47)
Ophthalmoplegic Migraine: Migrainous or Inflammatory? (2004) (47)
The anterior hypothalamus in cluster headache (2017) (47)
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations (2020) (47)
Metabolic profiling of ultrasmall sample volumes with GC/MS: from microliter to nanoliter samples. (2010) (47)
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection (2020) (47)
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies (2006) (47)
Cerebrovascular Reactivity Is a Main Determinant of White Matter Hyperintensity Progression in CADASIL (2009) (46)
Within-patient consistency of response of rizatriptan for treating migraine (2000) (46)
Migraine : pharmacology and genetics (1996) (46)
Plasma Interleukin-1, Tumour Necrosis Factor and Hypothalamic-Pituitary-Adrenal Axis Responses During Migraine Attacks (1991) (45)
Gene-based pleiotropy across migraine with aura and migraine without aura patient groups (2016) (44)
Blood Flow Velocity Changes in Migraine Attacks-A Transcranial Doppler Study (1991) (44)
311C90: Increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists (1997) (44)
Four new mutations of the CFTR gene (541delC, R347H, R352Q, E585X) detected by DGGE analysis in Italian CF patients, associated with different clinical phenotypes (1992) (44)
Comparison of clinical-radiological and molecular findings in hypochondroplasia. (1998) (44)
Migraine with aura and white matter abnormalities: Notch3 mutation (2000) (43)
Integrated PCR amplification and detection processes on a Lab-on-Chip platform: a new advanced solution for molecular diagnostics (2010) (43)
LMNA-associated myopathies (2014) (43)
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response (1996) (43)
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study (2004) (43)
Synaptic Gain-of-Function Effects of Mutant Cav2.1 Channels in a Mouse Model of Familial Hemiplegic Migraine Are Due to Increased Basal [Ca2+]i (2014) (43)
Bromocriptine‐induced trigeminal patient with a neuralgia attacks in a pituitary tumor (1988) (42)
Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation (2018) (42)
Systematic re-evaluation of genes from candidate gene association studies in migraine using a large genome-wide association data set (2016) (42)
Is stress a trigger factor for migraine? (2007) (42)
Migraine genetics (2003) (42)
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study (2010) (42)
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. (2001) (42)
Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large‐scale analysis of disorders of iron metabolism (2006) (42)
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. (2008) (41)
Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine. (2003) (41)
Metabolic profiling of mouse cerebrospinal fluid by sheathless CE-MS (2012) (41)
Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls (2013) (40)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine (2010) (40)
Search for Mitochondrial Dna Mutations in Migraine Subgroups (1999) (40)
Key questions about the future of laboratory medicine in the next decade of the 21st century: A report from the IFCC-Emerging Technologies Division. (2019) (40)
Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging (2019) (40)
Pearls and pitfalls in genetic studies of migraine (2013) (39)
Migraine Prophylaxis, Ischemic Depolarizations, and Stroke Outcomes in Mice (2015) (39)
Abnormal synaptic Ca2+ homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice (2015) (39)
An Overview of Current Microarray-Based Human Globin Gene Mutation Detection Methods (2007) (39)
Temperature-programmed capillary electrophoresis for detection of DNA point mutations. (1996) (39)
The impact of pharmacogenetics for migraine. (2001) (39)
Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. (2003) (39)
ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria. (2019) (38)
Double-gradient denaturing gradient gel electrophoresis assay for identification of L-ferritin iron-responsive element mutations responsible for hereditary hyperferritinemia-cataract syndrome: identification of the new mutation C14G. (2001) (38)
Case report: a subject with a mutation in the ATG start codon of L-ferritin has no haematological or neurological symptoms (2004) (38)
Denaturing HPLC profiling of the ABCA4 gene for reliable detection of allelic variations. (2004) (38)
Evaluation of different approaches for fetal DNA analysis from maternal plasma and nucleated blood cells. (1999) (38)
Calcium channel mutations and migraine (2002) (38)
Treatment effects and comorbid diseases in 58 patients with visual snow (2019) (38)
Gain of function in FHM-1 Cav2.1 knock-in mice is related to the shape of the action potential. (2010) (38)
Cluster headache and depression (2016) (37)
Scanning mutations of the 5′UTR regulatory sequence of l‐ferritin by denaturing high‐performance liquid chromatography: identification of new mutations (2003) (37)
Imaging mass spectrometry to visualize biomolecule distributions in mouse brain tissue following hemispheric cortical spreading depression. (2012) (37)
Volumetric brain changes in migraineurs from the general population (2017) (37)
TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation (2017) (37)
Alternating Hemiplegia of Childhood: No Mutations in the Familial Hemiplegic Migraine CACNA1A Gene (2000) (37)
Verapamil induced gingival enlargement in cluster headache (2004) (37)
Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan (1995) (36)
Gene co-expression analysis identifies brain regions and cell types involved in migraine pathophysiology: a GWAS-based study using the Allen Human Brain Atlas (2016) (36)
T1 relaxation in in vivo mouse brain at ultra‐high field (2007) (36)
Enhanced circadian phase resetting in R192Q Cav2.1 calcium channel migraine mice (2008) (36)
Reduced trigeminovascular cyclicity in patients with menstrually related migraine (2015) (35)
PRRT2 and hemiplegic migraine: A complex association (2014) (35)
Alternating hemiplegia of childhood: no mutations in the second familial hemiplegic migraine gene ATP1A2. (2004) (35)
Treatment of Migraine Attacks with Subcutaneous Sumatriptan: First Placebo-Controlled Study (1992) (35)
Clinicopathological and genetic studies of two further Italian families with cerebral autosomal dominant arteriopathy (1996) (35)
Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of β-thalassemia (2008) (35)
MRI findings in migraine. (2005) (35)
The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt. (1988) (35)
The 1-in-X Effect on the Subjective Assessment of Medical Probabilities (2011) (35)
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours (1998) (34)
The Mechanism of Functional Up-Regulation of P2X3 Receptors of Trigeminal Sensory Neurons in a Genetic Mouse Model of Familial Hemiplegic Migraine Type 1 (FHM-1) (2013) (34)
Involvement of a Ca 2+ Channel Gene in Familial Hemiplegic Migraine and Migraine With and Without Aura (1997) (34)
Genetics of migraine: an update with special attention to genetic comorbidity (2008) (34)
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification (2020) (33)
How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians (2005) (33)
Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment. (2012) (33)
Early visual function impairment in CADASIL (2003) (33)
Cortical Spreading Depression Causes Unique Dysregulation of Inflammatory Pathways in a Transgenic Mouse Model of Migraine (2016) (33)
Molecular diagnosis of genetic diseases. (1996) (32)
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination (2019) (32)
Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene. (2002) (32)
Lenticulostriate Arterial Lumina Are Normal in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A High-Field In Vivo MRI Study (2010) (32)
Amplification of 18 dystrophin gene exons in DMD/BMD patients: simultaneous resolution by capillary electrophoresis in sieving liquid polymers. (1995) (32)
Quantifying visual allodynia across migraine subtypes: the Leiden Visual Sensitivity Scale (2018) (32)
Conditional inactivation of the Cacna1a gene in transgenic mice (2006) (31)
Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. (1998) (31)
Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor. (1988) (31)
Migraine Mutations Impair Hippocampal Learning Despite Enhanced Long-Term Potentiation (2015) (31)
Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question (1991) (31)
Migraine and vascular disease biomarkers: A population-based case-control study (2018) (31)
Reduced sleep and low adenosinergic sensitivity in cacna1a R192Q mutant mice. (2013) (31)
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis (2019) (31)
High-throughput genetic characterization of a cohort of Brugada syndrome patients. (2015) (31)
Very High Prevalence of Right-to-Left Shunt on Transcranial Doppler in an Italian Family with Cerebral Autosomal Dominant Angiopathy with Subcortical Infarcts and Leukoencephalopathy (2001) (31)
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study (2012) (30)
Postdural puncture headache in migraineurs and nonheadache subjects (2013) (30)
Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine (2019) (30)
Detoxification in medication-overuse headache, a retrospective controlled follow-up study: Does care by a headache nurse lead to cure? (2016) (30)
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan (2011) (30)
Female sex hormones in men with migraine (2018) (30)
A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood (2015) (30)
Allodynia is associated with a higher prevalence of depression in migraine patients (2014) (30)
Clinical effects and mechanism of action of sumatriptan in migraine (1992) (30)
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse (2011) (30)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: progression of MR abnormalities in prospective 7-year follow-up study. (2008) (30)
The impact of a migraine attack and its after-effects on perceptual organization, attention, and working memory (2011) (30)
Should We Advise Patients to Treat Migraine Attacks Early? (2004) (30)
The use of multiattribute decision models in evaluating triptan treatment options in migraine (2005) (30)
Familial hemiplegic migraine: a ion channel disorder (2001) (29)
A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine (2020) (29)
Predicting the response to sumatriptan (2004) (29)
Evaluating the IHS Criteria for Cluster Headache – a Comparison between Patients Meeting all Criteria and Patients Failing One Criterion (2006) (29)
IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients (2020) (29)
Prophylactic treatment of migraine; the patient's view, a qualitative study (2012) (29)
Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2 (2008) (29)
Concordance of genetic risk across migraine subgroups: Impact on current and future genetic association studies (2015) (29)
Cerebral perfusion changes in migraineurs: a voxelwise comparison of interictal dynamic susceptibility contrast MRI measurements (2012) (29)
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease (2018) (29)
Seven Novel Additional Small Mutations and a New Alternative Splicing in the Human Dystrophin Gene Detected by Heteroduplex Analysis and Restricted RT-PCR Heteroduplex Analysis of Illegitimate Transcripts (1996) (28)
Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine (2015) (28)
COLD-PCR and microarray: two independent highly sensitive approaches allowing the identification of fetal paternally inherited mutations in maternal plasma (2016) (28)
Capillary zone electrophoresis of polymerase chain reaction‐amplified DNA fragments in polymer networks: The case of GATT microsatellites in cystic fibrosis (1994) (28)
Hereditary Spastic Paraplegia: Beyond Clinical Phenotypes toward a Unified Pattern of Central Nervous System Damage. (2015) (28)
Acute confusional migraine Case report and review of literature (1988) (28)
Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. (2003) (28)
Next Generation Sequencing: From Research Area to Clinical Practice (2018) (28)
Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia. (2015) (28)
Two novel SCN1A mutations identified in families with familial hemiplegic migraine (2014) (28)
Predictors of Migraine Headache Recurrence: A Pooled Analysis From the Eletriptan Database (2007) (28)
Auditory Evoked Potentials in the Assessment of Central Nervous System Effects of Antimigraine Drugs (1999) (28)
Symptom dimensions of affective disorders in migraine patients. (2015) (28)
Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry (2016) (27)
Allodynia in cluster headache (2017) (27)
Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy (2019) (27)
Sumatriptan in the treatment of migraine (1993) (27)
Stress hormone corticosterone enhances susceptibility to cortical spreading depression in familial hemiplegic migraine type 1 mutant mice (2015) (27)
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation. (2019) (27)
The comorbid relationship between migraine and epilepsy: a systematic review and meta‐analysis (2015) (27)
Ischemic and Hemorrhagic Stroke in Patients on Oral Anticoagulants After Reconstruction for Chronic Lower Limb Ischemia (1993) (27)
Short direct repeats at the breakpoints of a novel large deletion in the CFTR gene suggest a likely slipped mispairing mechanism (1996) (27)
Recurrent coma and fever in familial hemiplegic migraine type 2. A prospective 15-year follow-up of a large family with a novel ATP1A2 mutation (2017) (27)
Restless legs syndrome in migraine patients: prevalence and severity (2016) (27)
Linking migraine frequency with family history of migraine (2018) (27)
Human Isolated Coronary Artery Contraction To Sumatriptan: A Post Hoc Analysis (1999) (27)
Asymptomatic cores and paracrystalline mitochondrial inclusions in CADASIL (2002) (27)
Understanding migraine using dynamic network biomarkers (2014) (27)
Migraine and Cerebrovascular Atherosclerosis in Patients With Ischemic Stroke (2017) (27)
Familial hemiplegic migraine is associated with febrile seizures in an FHM2 family with a novel de novo ATP1A2 mutation (2009) (26)
Characterization of acetylcholine release and the compensatory contribution of non-Cav2.1 channels at motor nerve terminals of leaner Cav2.1-mutant mice (2007) (26)
Severe and progressive neurotransmitter release aberrations in familial hemiplegic migraine type 1 Cacna1a S218L knock-in mice. (2010) (26)
The 3p21.1-p21.3 Hereditary Vascular Retinopathy Locus Increases the Risk for Raynaud's Phenomenon and Migraine (2005) (26)
Alternating hemiplegia of childhood successfully treated with topiramate: 18 months of follow-up (2006) (26)
7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL (2012) (26)
Unusual clinical features and early brain MRI lesions in a family with cerebral autosomal dominant arteriopathy (1997) (26)
Feasibility Study for a Microchip‐Based Approach for Noninvasive Prenatal Diagnosis of Genetic Diseases (2004) (25)
Expanding the spectrum of genes responsible for hereditary motor neuropathies (2019) (25)
Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS[S] (2017) (25)
Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice. (2006) (25)
Syncope in migraine: the population-based CAMERA study. (2006) (25)
Blood Flow Velocities in the Vertebrobasilar System During Migraine Attacks a Transcranial Doppler Study (1992) (25)
Pharmacotherapy for Cluster Headache (2020) (25)
Incipient CADASIL. (2003) (25)
Corrigendum: Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine (2016) (25)
Familial hemiplegic migraine: involvement of a calcium neuronal channel. (1997) (25)
32 – Migraine as a Cerebral Ionopathy with Abnormal Central Sensory Processing* (2007) (24)
The biological clock in cluster headache: A review and hypothesis (2019) (24)
Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance. (1993) (24)
Familial hemiplegic migraine. (2008) (24)
Stepwise web-based questionnaires for diagnosing cluster headache: LUCA and QATCH (2013) (24)
2 A Cacna 1 a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression (2006) (24)
Fetal DNA in maternal plasma in twin pregnancies. (2003) (24)
Subcutaneous GR43175 in the Treatment of Acute Migraine: An International Study (1989) (24)
Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy (2010) (24)
Validation of double gradient denaturing gradient gel electrophoresis through multigenic retrospective analysis. (1999) (24)
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management (2004) (24)
Intracellular and Plasma Magnesium in Familial Hemiplegic Migraine and Migraine With and Without Aura (1994) (24)
Triptan overuse in the Dutch general population: A nationwide pharmaco-epidemiology database analysis in 6.7 million people (2011) (24)
Chronic cluster headache: a review (2005) (24)
The novel p . L 1649 Q mutation in the SCN 1 A epilepsy gene is associated with familial hemiplegic migraine : genetic and functional studies (2011) (24)
Capillary electrophoresis in polymer networks for analysis of PCR products: detection of delta F508 mutation in cystic fibrosis. (1994) (23)
Biochemical changes in the brain of hemiplegic migraine patients measured with 7 tesla 1H-MRS (2014) (23)
A hyperexcitability phenotype in mouse trigeminal sensory neurons expressing the R192Q Cacna1a missense mutation of familial hemiplegic migraine type-1 (2014) (23)
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine (2008) (23)
A novel LIPS assay for insulin autoantibodies (2018) (23)
Analysis of ferritin genes in Parkinson disease. (2007) (23)
Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome (2017) (23)
Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease (2018) (23)
X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene. (2017) (23)
Cross-trait analyses with migraine reveal widespread pleiotropy and suggest a vascular component to migraine headache (2020) (23)
Single-fiber EMG in familial hemiplegic migraine (2004) (23)
Biochemistry of migraine. (1992) (23)
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). (2004) (22)
Quantitative cortical synapse proteomics of a transgenic migraine mouse model with mutated CaV2.1 calcium channels (2010) (22)
Expression of the genes encoding basic fibroblastgrowth factor and its receptorin human granulosa cells (1993) (22)
First case of compound heterozygosity in Na,K-ATPase gene ATP1A2 in familial hemiplegic migraine (2007) (22)
A 3-Mb Region for the Familial Hemiplegic Migraine Locus on 19p13.1–p13.2: Exclusion of PRKCSH as a Candidate Gene (1996) (22)
Migraine Strikes as Neuronal Excitability Reaches a Tipping Point (2013) (22)
Plasma metabolic profiling after cortical spreading depression in a transgenic mouse model of hemiplegic migraine by capillary electrophoresis--mass spectrometry. (2015) (22)
Microfabricated solid-state ion-selective electrode probe for measuring potassium in the living rodent brain: Compatibility with DC-EEG recordings to study spreading depression (2015) (22)
Repeatability of the Intensity Dependence of Cortical Auditory Evoked Potentials in the Assessment of Cortical Information Processing (1999) (22)
Evaluation of human gene variant detection in amplicon pools by the GS-FLX parallel Pyrosequencer (2008) (21)
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis (2009) (21)
Spreading depolarizations increase delayed brain injury in a rat model of subarachnoid hemorrhage (2016) (21)
Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine (2007) (21)
Molecular Diagnostics by Microelectronic Microchips (2003) (21)
28 – Migraine as a Cerebral Ionopathy with Impaired Central Sensory Processing (2007) (21)
Alcoholic beverages as trigger factor and the effect on alcohol consumption behavior in patients with migraine (2019) (21)
Influence of gestational age on fetal deoxyribonucleic acid retrieval in maternal peripheral blood. (1997) (21)
Presynaptic CaV2.1 calcium channels carrying familial hemiplegic migraine mutation R192Q allow faster recovery from synaptic depression in mouse calyx of Held. (2012) (21)
Genetics of headaches. (2010) (21)
The Factor V Leiden Mutation (R506Q) is not a Major Risk Factor for Migrainous Cerebral Infarction (1997) (21)
Space Headache: A New Secondary Headache (2009) (21)
The role of clinical and neuroimaging features in the diagnosis of CADASIL (2018) (21)
Comparison of different depletion strategies for improving resolution of the human urine proteome (2010) (20)
Genetic models of migraine E I G H T CHAPTER 8 (20)
Mutant P/Q-type calcium channel electrophysiology and migraine. (2001) (20)
Cerebellar function and ischemic brain lesions in migraine patients from the general population (2017) (20)
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2016) (20)
Identifying a gene expression signature of cluster headache in blood (2017) (20)
Preventive treatment for migraine in primary care, a population-based study in the Netherlands (2013) (20)
Increased use of illicit drugs in a Dutch cluster headache population (2018) (20)
A nonsense mutation (R1158X) and a splicing mutation (3849 + 4A----G) in exon 19 of the cystic fibrosis transmembrane conductance regulator gene. (1992) (20)
Assessment of Peripheral Vascular Effects of Antimigraine Drugs in Humans (1995) (20)
Candidate-gene association study searching for genetic factors involved in migraine chronification (2015) (19)
Systemic right-to-left shunts, ischemic brain lesions, and persistent migraine activity (2016) (19)
The efficacy and safety of sc Alniditan vs. sc Sumatriptan in the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial (2001) (19)
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey (2020) (19)
Alternating hemiplegia of childhood: no mutations in the glutamate transporter EAAT1. (2006) (19)
The Phe‐124‐Cys and A‐161T Variants of the Human 5‐HT1B Receptor Gene Are Not Major Determinants of the Clinical Response to Sumatriptan (2007) (19)
Release of platelet Met-enkephalin, but not serotonin, in migraine A platelet response unique to migraine patients? (1989) (19)
HIF1A and MIF as potential predictive mRNA biomarkers of pre-eclampsia: a longitudinal prospective study in high risk population (2015) (19)
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey (2020) (19)
A four-generation Dutch family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), linked to chromosome 19p13 (1995) (19)
Methionine-enkephalin and serotonin in migraine and tension headache (1987) (18)
Chronobiology and Sleep in Cluster Headache (2019) (18)
Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies (2012) (18)
RVCL-S and CADASIL display distinct impaired vascular function (2018) (18)
Monthly Update: Central & Peripheral Nervous Systems: Pharmacology of antimigraine 5-HT1D receptor agonists (1996) (18)
Cluster headache: To scan or not to scan (2008) (18)
Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study (2014) (18)
Cluster‐Tic Syndrome: A Cross‐Sectional Study of Cluster Headache Patients (2013) (18)
New molecular approaches to Alzheimer's disease. (2019) (18)
Study of FTMT and ABCA4 genes in a patient affected by age-related macular degeneration: identification and analysis of new mutations (2012) (18)
Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers. (2012) (18)
Prioritizing treatment attributes and their impact on selecting an oral triptan: Results from the TRIPSTAR project (2004) (18)
Genetic predisposing factors to bronchopulmonary dysplasia: preliminary data from a multicentre study (2012) (18)
Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations. (1989) (17)
Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasia. (2019) (17)
The impact of headache on quality of life (2003) (17)
Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: A simulation study (2020) (17)
Molecular characterization of 21-hydroxylase deficiency in 70 Italian families. (1993) (17)
Are microarrays useful in the screening of ABCA4 mutations in Italian patients affected by macular degenerations? (2008) (17)
Rapid capillary zone electrophoresis in isoelectric histidine buffer: high resolution of the poly-T tract allelic variants in intron 8 of the CFTR gene. (1998) (17)
Evaluation of the new ICHD-III beta cluster headache criteria (2016) (17)
Should We Advise Patients to Treat Migraine Attacks Early: Methodologic Issues (2005) (17)
Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks. (1999) (17)
New trend in non-invasive prenatal diagnosis. (2015) (16)
Capillary zone electrophoresis in polymer networks of polymerase chain reaction-amplified oligonucleotides: the case of congenital adrenal hyperplasia. (1994) (16)
Factors Associated with Treatment Compliance and its Effects on Retention among Participants in a Court-Mandated Treatment Program (2010) (16)
Genotyping beta-globin gene mutations on copolymer-coated glass slides with the ligation detection reaction. (2008) (16)
Iron in deep brain nuclei in migraine? CAMERA follow-up MRI findings (2017) (16)
Typical Cluster Headache Caused by Granulomatous Pituitary Involvement (2007) (16)
Genetics of primary headaches. (1999) (16)
Simultaneous detection of delta F508, G542X, N1303K and 1717-1G-->A mutations in cystic fibrosis by capillary electrophoresis in polymer networks. (1994) (16)
Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients (2015) (16)
The clinical effectiveness of 311C90 in the acute treatment of migraine. (1996) (16)
Multiple testing in fetal gender determination from maternal blood by polymerase chain reaction (1998) (16)
Magnetic resonance angiography of the human middle meningeal artery: Implications for migraine (2006) (16)
Skewed X‐chromosome inactivation is not associated with premature ovarian failure in a large cohort of Italian patients (2006) (16)
Treatment preferences and the selection of acute migraine medications: results from a population-based survey (2004) (16)
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study. (2020) (16)
Valproate Reduces Delayed Brain Injury in a Rat Model of Subarachnoid Hemorrhage (2017) (16)
Detection of a de novo R1066H mutation in an Italian patient affected by cystic fibrosis (1996) (16)
Familial hemiplegic migraine treated by sodium valproate and lamotrigine (2014) (16)
Bovine isolated middle cerebral artery contractions to antimigraine drugs (1999) (15)
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome (2021) (15)
Migraine Genetics: A Fascinating Journey Towards Improved Migraine Therapy (2008) (15)
A proactive approach to migraine in primary care: a pragmatic randomized controlled trial (2012) (15)
Gene dosage-dependent transmitter release changes at neuromuscular synapses of Cacna 1 a R 192 Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness T H R E E CHAPTER 3 (2007) (15)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: structural MR imaging changes and apolipoprotein E genotype. (2006) (15)
Gabapentin in Migraine Prophylaxis: Is it Effective and Well Tolerated? (2002) (15)
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants. (2019) (15)
Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations (1995) (15)
Heterozygous TREX1 mutations in early-onset cerebrovascular disease (2013) (15)
Communicating Down syndrome risk according to maternal age: “1‐in‐X” effect on perceived risk (2015) (15)
Migraine Aura, Illusory Vertical Splitting, and Picasso (2000) (15)
Acute treatment of migraine attacks. (1995) (15)
De novo deletion removes a conserved motif in the C-terminus of ABCA4 and results in cone-rod dystrophy (2006) (15)
Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients. (2019) (15)
Microstructural white matter changes preceding white matter hyperintensities in migraine (2019) (15)
Denaturing HPLC analysis of DNA deletions and insertions (2003) (15)
No confirmation of visual evoked potential diagnostic test for migraine (1991) (14)
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial (2021) (14)
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial (2021) (14)
A New Microarray Substrate for Ultra-Sensitive Genotyping of KRAS and BRAF Gene Variants in Colorectal Cancer (2013) (14)
Combined early treatment in hemiplegic attacks related to CACNA1A encephalopathy with brain oedema: Blocking the cascade? (2017) (14)
Methionine‐Enkephalin in Migraine and Tension Headache. Differences Between Classic Migraine, Common Migraine and Tension Headache, and Changes During Attacks. (1990) (14)
Cystic fibrosis patients with liver disease are not genetically distinct. (1991) (14)
Identification and characterization of C1orf36, a transcript highly expressed in photoreceptor cells, and mutation analysis in retinitis pigmentosa. (2003) (14)
DNA microarray-based solid-phase PCR on copoly (DMA-NAS-MAPS) silicon coated slides: An example of relevant clinical application. (2016) (14)
Visual Evoked Potentials and Background EEG Activity in Migraine (1991) (14)
Toward a molecular genetic classification of familial hemiplegic migraine (2004) (14)
Ligase chain reaction assay for human mutations: the Sickle Cell by LCR assay. (1997) (13)
5-HT3 receptor antagonists and migraine therapy (2004) (13)
Prevalent cardiac phenotype resulting in heart transplantation in a novel LMNA gene duplication (2010) (13)
Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients. (2010) (13)
The -582A>G variant of the HAMP promoter is not associated with high serum ferritin levels in normal subjects (2010) (13)
CAG triplet analysis in families with androgen insensitivity syndrome by capillary electrophoresis in polymer networks. (1995) (13)
Tumefactive lesions in retinal vasculopathy with cerebral leucoencephalopathy and systemic manifestations (RVCL-S): a role for neuroinflammation? (2017) (13)
A genetic linkage study of schizophrenia to chromosome 5 markers in a Northern Italian population (1992) (13)
Brain atrophy following hemiplegic migraine attacks (2017) (13)
Prophylactic treatment of migraine by GPs: a qualitative study. (2012) (13)
Novel JAG1 Deletion Variant in Patient with Atypical Alagille Syndrome (2019) (13)
Different Approaches for Noninvasive Prenatal Diagnosis of Genetic Diseases Based on PNA‐Mediated Enriched PCR (2006) (13)
Involvement of astrocyte and oligodendrocyte gene sets in migraine (2016) (13)
Single-nucleotide polymorphism and mutation identification by the nanogen microelectronic chip technology. (2005) (13)
Role of atherosclerosis, clot extent, and penumbra volume in headache during ischemic stroke (2016) (13)
Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients (2018) (13)
Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants (2020) (13)
Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache (2021) (13)
Epilepsy in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (2007) (12)
Co-segregation of LMNA and PMP22 gene mutations in the same family (2005) (12)
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks (1992) (12)
Experimental studies on peripheral nerve repair following early or delayed suture. (1986) (12)
Wolff Award 1997. Involvement of a Ca2+ channel gene in familial hemiplegic migraine and migraine with and without aura. Dutch Migraine Genetics Research Group. (1997) (12)
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene (2019) (12)
An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP) (2015) (12)
Reduced ACh release at neuromuscular synapses of heterozygous leaner Cav2.1‐mutant mice (2008) (12)
Trigeminal autonomic cephalalgia-tic-like syndrome associated with a pontine tumour in a one year old girl (2003) (12)
Genetic factors in cluster headache (2003) (12)
Analysis of linkage disequilibrium between different cystic fibrosis mutations and three intragenic microsatellites in the Italian population (1995) (12)
Rapid detection of 1717-1G----A mutation in CFTR gene by PCR-mediated site-directed mutagenesis. (1991) (12)
Multiplex PCR for rapid detection of three mutations in the cystic fibrosis gene. (1992) (12)
Identification of an 18 bp deletion in the TWIST1 gene by CO-amplification at lower denaturation temperature-PCR (COLD-PCR) for non-invasive prenatal diagnosis of craniosynostosis: first case report (2014) (12)
SCN5A Nonsense Mutation and NF1 Frameshift Mutation in a Family With Brugada Syndrome and Neurofibromatosis (2019) (12)
Impairment of Trigeminal Sensory Pathways in Cluster Headache (2003) (12)
New discoveries about the second gene for familial hemiplegic migraine, ATP1A2 (2003) (11)
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype (2019) (11)
Cardiovascular Autonomic Function Tests in Cluster Headache (2006) (11)
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2–4 preventives were not useful: results from the LIBERTY study (2021) (11)
Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol. (1992) (11)
Transmitter Release Deficits at the Neuromuscular Synapse of Mice with Mutations in the Cav2.1 (α1A) Subunit of the P/Q‐Type Ca2+ Channel (2003) (11)
Tripstar: A Comprehensive Patient‐Based Approach to Compare Triptans (2002) (11)
Using Comparison Scenarios to Improve Prenatal Risk Communication (2013) (11)
High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene (2010) (11)
Circulating Endothelial Markers in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations (2017) (11)
A human capsaicin model to quantitatively assess salivary CGRP secretion (2015) (11)
Sunct Syndrome Resolving After Contralateral Hemispheric Ischaemic Stroke (2003) (10)
Relief of common migraine by exercise. (1987) (10)
Redundancy of Cav2.1 channel accessory subunits in transmitter release at the mouse neuromuscular junction (2007) (10)
Aura in Cluster Headache: A Cross‐Sectional Study (2018) (10)
Fatal respiratory failure in a full-term newborn with two ABCA3 gene mutations: a case report (2011) (10)
Space headache on Earth: Head-down-tilted bed rest studies simulating outer-space microgravity (2015) (10)
Aortic root pathology in Marfan syndrome increases the risk of migraine with aura (2012) (10)
RNA expression profiling in brains of familial hemiplegic migraine type 1 knock-in mice (2014) (10)
Detection of a novel dystrophin gene mutation through carrier analysis performed during prenatal diagnosis in a case with intragenic recombination (2005) (10)
Headache in people with epilepsy (2021) (10)
Infratentorial Microbleeds: Another Sign of Microangiopathy in Migraine (2015) (10)
Dopamine D2–Receptor Imaging With 123I-Iodobenzamide SPECT in Migraine Patients Abusing Ergotamine: Does Ergotamine Cross The Blood Brain Barrier? (1993) (10)
Visual evoked responses in children with migraine (1990) (10)
Cystogenic potential of CD133+ progenitor cells of human polycystic kidneys (2011) (10)
From chance to choice: The use of a verbal analogy in the communication of risk (2010) (10)
Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease (2014) (10)
Fetal DNA in maternal plasma: a noninvasive tool for prenatal diagnosis of beta-thalassemia (2012) (10)
Concomitant Headache Influences Long-term Prognosis After Acute Cerebral Ischemia of Noncardioembolic Origin (2013) (10)
Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study (2020) (10)
Cardiac monitoring of high-dose verapamil in cluster headache: An international Delphi study (2016) (9)
MRI evaluation of the relationship between carotid artery endothelial shear stress and brain white matter lesions in migraine (2019) (9)
Metabolomic changes in CSF of migraine patients measured with 1H-NMR spectroscopy. (2016) (9)
Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders (2010) (9)
Null ABCA3 in humans: Large homozygous ABCA3 deletion, correlation to clinical–pathological findings (2014) (9)
Rapid detection of 21-hydroxylase deficiency mutations by allele-specific in vitro amplification and capillary zone electrophoresis. (1997) (9)
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study (2021) (9)
Prevalence of lifetime depression in a large hemiplegic migraine cohort (2016) (9)
Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour DNA Mutations (2019) (9)
The Transition G To A at Position 20210 in the 3'-Untranslated Region of the Prothrombin Gene is Not Associated with Migrainous Infarction (1998) (9)
Headache: the changing migraine brain (2013) (9)
Ethanol contamination of cerebrospinal fluid during standardized sampling and its effect on 1H-NMR metabolomics (2015) (9)
A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia. (2020) (9)
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA (2017) (9)
A long-term follow-up study of 18 patients with sporadic hemiplegic migraine (2011) (9)
Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without (2021) (9)
Familial hemiplegic migraine in The Netherlands. Dutch Migraine Genetics Research Group. (1994) (9)
Erratum: Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families (Neuron (2018) 98(4) (743–753.e4), (S0896627318303222) (10.1016/j.neuron.2018.04.014)) (2018) (9)
Mutational analysis of muscle and brain specific promoter regions of dystrophin gene in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE). (1995) (8)
Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study (2012) (8)
Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice (2019) (8)
Migraine and epilepsy: genetically linked? (2008) (8)
Development of new substrates for high‐sensitive genotyping of minority mutated alleles (2008) (8)
The E1015K Variant in the Synprint Region of the CaV2.1 Channel Alters Channel Function and Is Associated with Different Migraine Phenotypes* (2013) (8)
Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches (2018) (8)
An evaluation of the Diamat HPLC analyser for simultaneous determination of haemoglobins A2 and F (1989) (8)
Long-term Efficacy and Safety of Erenumab (2021) (8)
Optimized Detection of DNA Point Mutations by Double Gradient Denaturing Gradient Gel (1998) (8)
Transient Resolution of Headache in Giant Cell Temporal Arteritis After Sumatriptan (1993) (8)
COLD-PCR and innovative microarray substrates for detecting and genotyping MPL exon 10 W515 substitutions. (2012) (8)
No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache. (2001) (8)
High‐throughput mutational screening for beta‐thalassemia by single‐nucleotide extension (2007) (7)
Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories. (2014) (7)
Genetic susceptibility to neonatal lung diseases. (2012) (7)
High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma (2009) (7)
A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy ameliorates hereditary spastic paraparesis due to spastin mutation (2015) (7)
Erratum: Genetic and clinical heterogeneity of ferroportin disease (British Journal of Haematology (2005) 131, (663-670)) (2006) (7)
Mutated CaV2.1 channels dysregulate CASK/P2X3 signaling in mouse trigeminal sensory neurons of R192Q Cacna1a knock-in mice (2013) (7)
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: findings from the randomised, double-blind, sham-controlled ACT2 study (2017) (7)
Efficacy and Tolerability of ICS 205–930, A 5-HT3 Receptor Antagonist, in Migraine Prophylaxis (1989) (7)
Genetics and pathology of voltage-gated Ca2+ channels. (1998) (7)
Generation of β cells from iPSC of a MODY8 patient with a novel mutation in the carboxyl ester lipase (CEL) gene. (2021) (7)
Migraine: new treatment options from molecular biology (2005) (7)
Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome (2019) (7)
Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling (2018) (7)
Phase clustering in transcranial magnetic stimulation-evoked EEG responses in genetic generalized epilepsy and migraine (2019) (6)
The genetics of migraine: implication for treatment approaches. (2002) (6)
Magnetic evoked potentials (MEPs) are larger in left-handed subjects. (1994) (6)
Familial hemiplegic migraine type-1 mutated cav2.1 calcium channels alter inhibitory and excitatory synaptic transmission in the lateral superior olive of mice (2015) (6)
The cavernous sinus in cluster headache – a quantitative structural magnetic resonance imaging study (2017) (6)
Circle of Willis variations in migraine patients with ischemic stroke (2019) (6)
Trigeminal Autonomic Cephalgias Due to Structural Lesions (2016) (6)
Heritability of migraine: Genetic findings (2003) (6)
Stroke progression and clinical outcome in ischemic stroke patients with a history of migraine (2019) (6)
The adverse effects of antiepileptic drugs differ in patients with migraine (2012) (6)
Chorea and Migraine: “Hemicrania Choreatica”? (1984) (6)
FETAL DIAGNOSIS OF β-THALASSAEMIA BY DNA ANALYSIS IN ITALY (1986) (6)
Regional distribution of cystic fibrosis linked DNA haplotypes in Italy, a collaborative study. (1990) (6)
Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency (1990) (6)
Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis DNA sequencing in Mycobacterium tuberculosis clinical isolates. (2003) (6)
Rapid Prototyping of Organ-on-a-Chip Devices Using Maskless Photolithography (2021) (6)
Migraine, tolosa-hunt syndrome and pleocytosis Correlation or coincidence? (1984) (6)
Peripheral neuropathy in Cockayne syndrome (1986) (6)
Reproducibility and Feasibility of Neurophysiological Assessment of the Sensory Trigeminal System for Future Application To Paroxysmal Headaches (2002) (6)
Dihydroergotamine nasal spray (1995) (5)
Association of LOXIN, a new functional splicing isoform of the OLR1 gene, with severity and prognostic localization of critical coronary artery stenoses (2014) (5)
Amplification refractory mutation system analysis of point mutations by capillary electrophoresis. (2001) (5)
First report of three cystic fibrosis patients homozygous for the 1717-1G-->A mutation. (1996) (5)
Sumatriptan by Injection (2001) (5)
Unusual early recurrence of granular dystrophy after deep anterior lamellar keratoplasty: case report. (2013) (5)
Laboratory medicine meets precision medicine: The paradigm of metabolomics in perinatology: Proposals from the 4th International Conference on Neonatal and Pediatric Laboratory Medicine. (2015) (5)
A Gene for a New Monogenic Neurovascular Migraine Syndrome: A Next Step in Unravelling Molecular Pathways for Migraine? (2008) (5)
Informativity of intragenic microsatellites for carrier detection and prenatal diagnosis of cystic fibrosis in the Italian population (1994) (5)
The quest for migraine genes (1997) (5)
CGRP receptor antagonists in the treatment of migraine (2010) (5)
Point mutation detection by temperature-programmed capillary electrophoresis. (2001) (5)
[Klippel-Trenaunay syndrome: case report]. (2010) (5)
Conditional inactivation of the Cacna 1 a gene in transgenic mice S I X CHAPTER 6 (2007) (5)
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults (2019) (5)
CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology (2009) (4)
Current perspectives on effective migraine treatments: are small clinical differences important for patients? (2003) (4)
[Gammahydroxybutyrate must remain available for patients with narcolepsy]. (1999) (4)
Responsivity to light in familial hemiplegic migraine type 1 mutant mice reveals frequency‐dependent enhancement of visual network excitability (2020) (4)
Association study in migraine. (1995) (4)
Molecular characterization of hemoglobin C in sicily (1992) (4)
Development of a neural probe to measure potassium during a cortical spreading depression in-vivo (2013) (4)
Simultaneous detection of fourteen Italian cystic fibrosis mutations in seven exons by reverse dot-blot analysis. (1995) (4)
Molecular diagnostics by microelectronic microchips (2005) (4)
Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing (2020) (4)
Myopathy as paraneoplastic syndrome of colon malignancy in an elderly patient (2013) (4)
Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32. (2001) (4)
NOn-invasive Vagus nerve stimulation in acute Ischemic Stroke (NOVIS): a study protocol for a randomized clinical trial (2020) (4)
Compound heterozygous SCN5A gene mutations in asymptomatic Brugada syndrome child (2012) (4)
A novel MEN1 gene mutation. (2008) (4)
Hypothalamic functional MRI activity in the initiation phase of spontaneous and glyceryl trinitrate‐induced migraine attacks (2021) (4)
Picasso’s migraine: Illusory cubist splitting or illusion? (2011) (4)
ZAP-70 expression in chronic lymphocytic leukemia: a new parameter for an old disease (2003) (4)
THE PHARMACOLOGY OF ANTIMIGRAINOUS DRUGS (1992) (4)
MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer (2019) (3)
CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab (2022) (3)
Single nucleotide polymorphism and mutation identification by microelectronic chip technology (2002) (3)
[Aura-related symptoms associated with cluster headache: outcomes of a LUCA substudy]. (2013) (3)
Response to letter from MaassenVanDenBrink et al. (2008) (3)
Different approaches of molecular scanning of point mutations in genetic diseases (1996) (3)
10. Circulating Nucleic Acids as Diagnostic Tool (2008) (3)
Emerging preclinical and clinical profile of 311C90: a poster review and discussion. (1996) (3)
An early 18th-century case description of cluster headache (2010) (3)
Mahler's Migraine (2000) (3)
CIRCULATING NUCLEIC ACIDS AS DIAGNOSTIC TOOL (2008) (3)
Oxford Textbook of Headache Syndromes (2020) (3)
Chronic frequent headache in the general population (1999) (3)
Dual‐color microchip electrophoresis with single‐photon avalanche diodes: Application to mutation detection (2008) (3)
Cannabidiol and the central nervous system: translating into clinics (2021) (3)
Beyond the cardiovascular risk charts: the new way of hybrid profiles. (2016) (3)
Migraine: And Other Headaches (1989) (3)
A child with severe pneumomediastinum and ABCA3 gene mutation: a puzzling connection. (2012) (3)
No indication for patent foramen ovale closure in migraine (2009) (3)
Enhanced pre-ictal cortical responsivity in migraine patients assessed by visual chirp stimulation (2020) (3)
Evidence for the single origin of HB G-San Jose in Sicily. (1989) (3)
A Patient with Long-Lasting Attacks of Bilateral ‘Blepharospasm’, Photophobia, Lacrimation and Rhinorrhoea (2004) (3)
Molecular scanning of the ABCA4 gene in Spanish patients with retinitis pigmentosa and Stargardt disease: Identification of novel mutations. (2007) (3)
Abnormal cardiovascular response to nitroglycerin in migraine (2019) (3)
Ergot Alkaloids Reduce Cranial Arteriovenous Shunting In Pigs: No Major Role for 5-Ht1-Like Receptors (1991) (3)
Sleep spindles and spike-wave discharges in rats : effects of thalamic lesions (2005) (3)
A fast microelectronic array for screening and prenatal diagnosis of beta-thalassemia. (2008) (3)
Molecular Scanning of the ABCA4 Gene in Spanish Patients with Retinitis Pigmentosa and Stargardt Disease: Identification of Novel Mutations (2007) (2)
[Preventive treatment for migraine]. (2010) (2)
Auditory Event-Related Potentials Change during Migraine Attacks without Aura (1989) (2)
Right-to-left shunts and micro-embolization in migraine. (2012) (2)
Nerve conduction sensitivity in diabetic neuropathy (1999) (2)
Monoamine Oxidase, Phenolsulph Otransferase And Serotonin Metabolism In Common And Classic Migraine And Tension Headache (1987) (2)
A breathtaking headache (2004) (2)
Sex Differences in Risk Profile, Stroke Cause and Outcome in Ischemic Stroke Patients With and Without Migraine (2021) (2)
Leiden Visual Sensitivity Scale (2019) (2)
Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies (2013) (2)
Cortical glutamate and gamma-aminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study (2021) (2)
Genetic factors predisposing to bronchopulmonary dysplasia. A pilot study by exome sequencing and pathways analysis (2015) (2)
Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction (2021) (2)
Advancing the education in molecular diagnostics: the IFCC-Initiative "Clinical Molecular Biology Curriculum" (C-CMBC); a ten-year experience. (2014) (2)
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs. (1999) (2)
Fetal DNA Analysis from Maternal Plasma and Nucleated Blood Cells (2000) (2)
Rizatriptan: A New Milestone in Migraine Treatment (1999) (2)
Prenatal diagnosis and linkage disequilibrium with cystic fibrosis for markers surrounding D7S8 (1990) (2)
[Migraine: diagnosis, pathophysiology and therapy]. (1987) (2)
Migraine as a process - challenges in the effective management of migraine. (2008) (2)
Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts (2010) (2)
Plasma Amino Acids In Common And Classic Migraine And Tension Headache (1987) (2)
The role of catastrophizing and locus of control in chronic frequent headache (2008) (2)
[Migraine and depression should be treated concurrently]. (2010) (2)
096 Assessment of the efficacy of erenumab during the open-label treatment (13–24 weeks) of subjects with episodic migraine who failed 2–4 prior preventive treatments: results of the LIBERTY study (2019) (2)
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 (2019) (2)
Time lost due to an attack – a novel patient-reported outcome measure for acute migraine treatments (2021) (2)
Hemiplegic Migraine and Channel Disorders (2009) (2)
Waarschuwingssignalen voor acute verergering van chronische ziekten ; Early warning signs for acute episodes in chronic diseases (2015) (2)
G.P.4.05 Phenotypic clustering of lamin A/C mutations in neuromuscular patients (2006) (1)
An improved methodological approach for the analysis of cell-free RNA in maternal plasma (2011) (1)
A recombination event in the closely linked plasminogen and apolipoprotein(a) gene loci (1995) (1)
A nonsense mutation (Gln-673-Term) in exon 17 of the human dystrophin gene detected by heteroduplex analysis (1995) (1)
Genetic surfactant dysfunction in newborn infants and children with acute and chronic lung disease (2017) (1)
Sequencing of Von Hippel-Lindau (VHL) Gene from Genomic DNA for Mutation Detection in Italian Patients (2006) (1)
Diagnosis of genetic diseases by DNA technology (1991) (1)
[From gene to disease; from CACNA1A to migraine]. (2001) (1)
Migraine Genes—Clinical and Preclinical Perspectives (2012) (1)
Migraine as a Risk Factor for White Matter Lesions, Silent Infarctions, and Ischemic Stroke: The Evidence for a Link (2005) (1)
Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study (2016) (1)
Postural sway in migraine patients and controls, results from a population based CAMERA-2 study (2013) (1)
Hemiplegic and Basilar-type Migraine: Current and Future Treatment (2006) (1)
Novel SCN1A mutation in the IFMT motif of the α1 subunit of the voltage-gated NaV1.1 channel causing familial hemiplegic migraine (2013) (1)
Genetics of Monogenic and Complex Migraine (2017) (1)
Occipital Nerve Stimulation for Attack Prevention in Medically Intractable Chronic Cluster Headache: The Randomized, Double-Blind, Electrical Dose-Controlled ICON Study (2020) (1)
Proactieve benadering van migraine (2012) (1)
REPRINTED WITH PERMISSION OF IASP - Allodynia in cluster headache (2019) (1)
Efficacy of frovatriptan versus almotriptan for acute treatmentof menstrual migraine: analysis of a double-blind, randomized,crossover, multicentre Italian, comparative study (2012) (1)
Assessment of the Efficacy of Erenumab During the Open-Label Treatment (13–24 Weeks) of Subjects with Episodic Migraine Who Failed 2–4 Prior Preventive Treatments: Results of the LIBERTY Study (P1.10-002) (2019) (1)
Migraine without aura: genome-wide association analysis identifies several novel susceptibility (2013) (1)
Unilateral increased visual sensitivity in cluster headache: a cross-sectional study (2022) (1)
CHAPTER 4 The 3 p 21 . 1p 21 . 3 hereditary vascular retinopathy locus increases the risk for Raynaud phenomenon and migraine (2006) (1)
Dominant lamin A/C gene mutations can be associated with muscular dystrophy and peripheral neuropathy (2004) (1)
Reduced ACh Release at Neuromuscular Synapses of Heterozygous Leaner Mice (2007) (1)
Migraine with Aura: A CADASIL Case (2015) (1)
Study on mutations and antiretroviral therapy (SMART): preliminary results. (1999) (1)
Therapeutic gain or therapeutic ratio? (2003) (1)
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine (2019) (1)
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks (2022) (1)
Repeated greater occipital nerve injections with corticosteroids in medically intractable chronic cluster headache: a retrospective study (2021) (1)
Serotonin, NO, and CGRP and Headache (2011) (1)
CaV2.1 channel mutations causing familial hemiplegic migraine type 1 increase the susceptibility for cortical spreading depolarizations and seizures and worsen outcome after experimental traumatic brain injury (2021) (1)
Nonlinear visual processing is faster in migraine with aura (2017) (1)
Primary headaches. (2017) (1)
Voxel-Based Morphometry in Hypocretin-Deficient Narcolepsy NARCOLEPSY (2003) (1)
Effect of Sumatriptan on Cerebral Bloodflow During and Outside Migraine Attacks: A Tc-99M Hmpao Spect and Transcranial Doppler Study. (1991) (1)
19th biennial IPEG Meeting (2016) (1)
George W. Bruyn, Born Delft, 14 December 1928, Died La Salvetat, 23 June 2002 (2002) (1)
[Still no proof of the efficacy of acupuncture in the prevention of migraine]. (2005) (1)
The effect of needle size on cerebrospinal fluid collection time and post‐dural puncture headache: A retrospective cohort study (2021) (1)
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid (2022) (1)
Flow Velocity Changes in Migraine: A Transcranial Doppler Study (1989) (1)
Triptan medications to treat acute migraine (2002) (1)
Anatomical Variations in the Circle of Willis and Migraine Susceptibility: Is There an Association? (2010) (1)
GAIN OF FUNCTION IN FHM-1 CAV 2 . 1 KNOCKIN MICE IS RELATED TO THE SHAPE OF 1 THE ACTION POTENTIAL 2 (2010) (1)
From genetics to prophylaxis (1997) (1)
[From gene to disease; from Notch3 to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy]. (2001) (1)
[From gene to disease; familial hemiplegic migraine as a result of mutations in a sodium-potassium pump gene]. (2004) (1)
IHC Posters - Thursday and Friday (2017) (1)
Relapse in acute migraine treatment: Comparison of frovatriptan with other triptans (2013) (1)
Genetic testing in neurology exploiting next generation sequencing: state of art (2019) (1)
Temperature-Tolerant COLD-PCR Eliminates Temperature Stringency and Enables Robust Mutation Enrichment (2012) (1)
The 7th EFCC Continuous Postgraduate Course in Clinical Chemistry: New trends in diagnosis, monitoring and management using molecular diagnosis methods (2007) (1)
A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility (2022) (0)
Integrating brain gene expression data with genome-wide association data links several brain regions and gene functions to migraine pathophysiology (2015) (0)
[Migraine and cardiovascular risk]. (2007) (0)
New developments in migraine science: preference, practice, and theory (2002) (0)
Vascular Effects of Serotonin in Migraine Patients (1989) (0)
2. Post-Natal Molecular Diagnosis of Inherited Diseases (2008) (0)
MIGRAINE GENETICS, A FASCINATING STORY TOWARDS BETTER MIGRAINE PROPHYLACTICS (2008) (0)
Chapter 2 Chronic frequent headache in the general population-prevalence and associated factors – (2008) (0)
A new polymorphism in exon 14 of the dystrophin gene detected by RT-PCR and DGGE. (1997) (0)
W234 Prevalence of dyspermia in infertile African black men (2022) (0)
Dysregulation of inflammatory pathways in a Familial Hemiplegic Migraine 1 mouse model after the induction of cortical spreading depression (2013) (0)
Prothrombotic mutations and ischaemic stroke at a young age in two sisters (1998) (0)
Application of pyrosequencing to the identification of sequence variations in the cystic fibrosis transmembrane conductance regulator gene (2009) (0)
No Direct Effect of Topiramate on Wild-Type and Mutant CaV2.1 Channels Mediating Acetylcholine Release at Mouse Neuromuscular Synapses (2007) (0)
Molecular scanning for point mutations in DMD/BMD (1996) (0)
METABOLIC CHANGES IN THE CSF OF MIGRAINE PATIENTS – MEASURED WITH NMR (2016) (0)
Visual snow (2020) (0)
Screening forNon-DeltaF508 Mutations inFiveExonsofthe Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)GeneinItaly (1991) (0)
Subject Index Vol. 46, 2001 (2001) (0)
Frovatriptan versus other triptans in the acute treatment of migraine with aura attacks: Pooled analysis of double-blind, randomized, cross-over, multicenter, studies (2013) (0)
Effects of stimulus intensity, coil orientation and handedness on magnetic cortical stimulation (1993) (0)
Intra- and interindividual attack frequency variability of chronic cluster headache (2023) (0)
myeloproliferative disorders Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative (2013) (0)
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders (2019) (0)
pressure palsy (HNPP) hereditary neuropathy with liability to immunoglobulin G for inflammation in An n-of-one RCT for intravenous (2015) (0)
Cluster headache and other trigeminal autonomic cephalalgias (2020) (0)
Evaluation of the Universal Master Mix (STAT-NAT DNA-Mix) for reliable molecular testing (2012) (0)
Strategies for the prevention of Duchenne's muscular dystrophy in Lombardia (1987) (0)
Mutational Status of TET2, JAK2, and MPL in Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis. (2009) (0)
Ischemic andHemorrhagic Stroke inPatients on OralAnticoagulants After Reconstruction for Chronic LowerLimbIschemia (1993) (0)
Board Walk -- April 2013 (2013) (0)
5. Effect of sumatriptan on cerebral blood flow during migraine attacks: a transcranial Doppler study (1992) (0)
eNhaNceD GraNule cell output aND irreGular purKiNje cell firiNG iN GaiN-of-fuNctioN CaCna1a S218L mutatioN (2010) (0)
Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling (2018) (0)
Sustained reduction of migraine headache days in patients with episodic migraine during months 4–6 of treatment with galcanezumab (2019) (0)
DNA technology for prenatal diagnosis of cystic fibrosis in Italy. (1991) (0)
Reply. (2019) (0)
Molecular genetic overlap between migraine and major depressive disorder (2018) (0)
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache (2022) (0)
Cerebrospinal Fluid and Plasma Amine Profiles in Interictal Migraine (2022) (0)
A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine (2020) (0)
Epigenetic signatures of migraine genes in a transgenic mouse model of familial hemiplegic migraine (2017) (0)
Evaluation of damaging effects of splicing mutations: Validation of a method useful to diagnostic laboratories (2013) (0)
['Migraine and a hole in the heart': causal relationship between migraine and patent foramen ovale not established]. (2006) (0)
International Headache Congress: 7th Congress, Toronto, September 1995 311C90: Further Advances in the Pathogenesis and Acute Treatment of Migraine (1996) (0)
6 Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis (2015) (0)
Neuropathic pain: strategies for successful patient management (2002) (0)
[Trigeminal autonomic cephalalgias: three forms of unilateral, short-lasting headache with facial autonomic symptoms]. (2008) (0)
Clinically relevant designs and outcome measures for acute migraine trials (2008) (0)
The adverse eff ects of antiepileptic drugs diff er in patients with migraine (2012) (0)
Gene expression profiling in Familial Hemiplegic Migraine mice (2012) (0)
Morphological assessment and validation of the transgenic Cacna1a knockin migraine mouse model by in vivo MRI (2011) (0)
Intractable Headache Criteria: Reply (2007) (0)
TMS-evoked EEG potentials demonstrate altered cortical excitability in migraine with aura (2023) (0)
MIGR AINe PROPHyL A XIS, ISCHe MIC DePOL ARIZ ATIONS, AND STROKe OUTCOMeS IN MICe (2016) (0)
Reply (2006) (0)
PRESYNAPTIC CaV 2 . 1 CALCIUM CHANNELS CARRYING A FAMILIAL HEMIPLEGIC 1 MIGRAINEMUTATION R 192 Q ALLOW FASTER RECOVERY FROM SYNAPTIC 2 DEPRESSION IN MOUSE CALYX OF HELD (2012) (0)
Near infrared spectroscopy applied to metabolic myopathies: a combined MRS and NIRS approach (2001) (0)
Scientific Meeting of Netherlands Society of Neurology Held in Amersfoort, 9th and 10th December 1988 (1989) (0)
Gene co-expression analysis identifies brain regions and cell types involved in migraine pathophysiology: a GWAS-based study using the Allen Human Brain Atlas (2016) (0)
Contents Vol. 46, 2001 (2001) (0)
Failure to detect Glut4-Ile383 and IR-Gln1152 variants in NIDDM (non-insulin dependent diabetes mellitus) and control subjects in an Italian population (2004) (0)
Non-invasive prenatal diagnosis of genetic diseases by advanced technologies (2013) (0)
An evaluation of the Diamat HPLC analyser (1989) (0)
Impairment of trigeminal sensory pathways in cluster headache. (2004) (0)
Editorial (1995) (0)
Search for candidate genes in common Migraine in the Italian population. (2000) (0)
IHC Electronic Posters – Thursday and Friday Headache Pathophysiology-Imaging and Neurophysiology EP-01-001 Ambient light color variably influences migraine pain intensity and discomfort in the ictal and interictal phase (2017) (0)
A linkage study in Italian schizophrenic families Testing the chromosome 5 hypothesis (1993) (0)
Chapter 3 Chronic frequent headache in the general population-comorbidity and quality of life (2008) (0)
Iron Accumulation in Migraine (2012) (0)
[Channelopathies: a genetic explanation of migraine and other paroxysmal neurologic disorders]. (1998) (0)
311C90 : further advances in the pathogenesis and acute treatment of migraine : 7th International Headache Congress, Toronto, Canada, September 20, 1995 (1996) (0)
Space Headache During Long-Haul Flights in 66 Astronauts (2022) (0)
Displasia fibrosa da mandíbula Fibrous dysplasia of mandible (2010) (0)
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease (2020) (0)
Molecular characterization of Philadelphia-negative myeloproliferative neoplasms (2010) (0)
CACNA1A gene mutations in familial hemiplegic migraine (2000) (0)
Retinal photography: A diagnostic tool for small vessel disease of the brain? (2009) (0)
Cortical Spreading Depression Causes Unique Dysregulation of Inflammatory Pathways in a Transgenic Mouse Model of Migraine (2016) (0)
FHM 1 S 218 L Knockin Mouse Model to study Hemiplegic Migraine , Ataxia and Mild Head Trauma-triggered Sudden (2007) (0)
Post-Natal Molecular Diagnosis Of Inherited Diseases (2012) (0)
P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study (2018) (0)
PC.01.5: An Interdisciplinary Model in Identification of GI Syndromic Cancers Using NGS (2017) (0)
Migraine is not associated with enhanced atherosclerosis 7 (2015) (0)
Monitoring cortical neuronal activity and spreading depression in freely behaving familial hemiplegic migraine Cacna1a R192Q knockin mice (2013) (0)
Severe and Progressive Neurotransmitter Release Aberrations in a Novel Familial Hemiplegic Migraine Cacna1a S218L Knock-In Mouse (2007) (0)
Controverse over term 'retinale migraine' (2010) (0)
Towards Automation for Molecular Diagnosis of Cancer (2005) (0)
A GENOMIC APPROACH TO IDENTIFY NEW GENES RESPONSIBLE FOR INHERITED MOTOR AND CMT2 NEUROPATHIES: A COLLABORATIVE STUDY (2016) (0)
Corticosterone enhances CSD susceptibility via glucocorticoid receptor activation in familial hemiplegic migraine 1 Cacna1a knock-in mice (2013) (0)
Adherence to Treatment in Organ Transplantation: 1282 (2012) (0)
[Xenotransplantation: therapeutic strategy, but zoonotic risk] (2006) (0)
The new frontiers of surgery in veterinary medicine. (2010) (0)
Structural and Functional MRI Signatures of ALS Patients with C9ORF72 Hexanucleotide Repeat Expansion (P4.014) (2016) (0)
Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study (2013) (0)
[Amelogenesis imperfecta. Pathogenetic aspects and therapeutic guidelines]. (1987) (0)
A new technology for laboratory medicine (2013) (0)
Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies (1988) (0)
Rizatriptan: A New Milestone in Migraine Treatment. Introduction∗ (2000) (0)
[Experience with liver transplantation at the University of Chicago]. (1987) (0)
Mutation detection by Amplification Refractory Mutation System ( ARMS) and microchip electrophoresis (2006) (0)
perforant path-dentate gyrus synapses in vivo depression and slow onset long-term potentiation at Low-frequency stimulation induces long-term (2015) (0)
Revision 1 : Manuscript JCBFM-0068-07-ORIG Hypoxia-Induced Acute Mountain Sickness is Associated With Intracellular Cerebral Edema . A 3 Tesla Magnetic Resonance Imaging Study (2009) (0)
66 MIGRAINE AS A CEREBRAL IONOPATHY — WHY DO MIGRAINEURS GET ATTACKS? (2006) (0)
Personalized medicine: A new model for primary and secondary pancreatic neoplasia prevention (2015) (0)
Reduced Presynaptic Signaling in Retinal Neurons of a Transgenic Mouse Model for Familial Hemiplegic Migraine (2010) (0)
Reply - Intractable headache criteria (2007) (0)
Quantitative Analysis of Fetal DNA in Maternal Plasma in Preeclamptic Pregnancies (2001) (0)
R192Q knockin migraine mouse model: increased susceptibility to cortical spreading depression and cerebellar MRI abnormalities (2007) (0)
An Open-Source Tool for Managing Time-Evolving Variant Annotation (2017) (0)
TIPS 1346 No . of Pages 10 Review Wiping Out CGRP : Potential Cardiovascular Risks (2016) (0)
Pathophysiology of paroxysmal and chronic degenerative progressive disorder of the central and periferal nervous system (2003) (0)
Methodology driven differences in physiological parameters influence characteristics of cortical spreading depression in wild-type and familial hemiplegic migraine type 1 mice (2016) (0)
4792Late gadolinium enhancement and arrhythmic risk prediction in patients with LMNA-related cardiomyopathy: results from a long-term follow-up multicenter study (2017) (0)
Letters to the editor (1994) (0)
Research Submission Aura in Cluster Headache: A Cross-Sectional Study (2018) (0)
65 Topical Seminar Summary: MIGRAINE GENES AND MECHANISMS: THREE PAINFUL QUESTIONS (2006) (0)
Integrating migraine GWAS data with brain expression information for functional interpretation of migraine-associated SNPsin (2015) (0)
From molecules to migraine patient : proceedings of the 2nd International Congress of the European Headache Federation in Liège, June 1994 (1995) (0)
Chapter 7 Discrete differences in brain perfusion between migraineurs and controls : a voxelwise comparison of interictal dynamic susceptibility contrast MrI measurements (2011) (0)
Frequency of the ΔF508 mutation in a sample of 175 Italian cystic fibrosis patients (1990) (0)
Chapter 5 Imaging mass spectrometry to visualize biomolecule distributions in mouse brain tissue following hemispheric cortical spreading depression (2016) (0)
A pilot model for risk stratification of Brugada patients based on genotype (2013) (0)
Prevention of cystic fibrosis in Italian families by DNA studies. (1990) (0)
Migraine without aura: genome-wide association analysis identifies several novel susceptibility (2013) (0)
The Second International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS-2) held in conjunction with the 6th Annual Scientific Symposium of the Hong Kong Cancer Institute (2001) (0)
Migraine and Brain Lesions (2012) (0)
Authors' Reply: Abdominal Migraine (2003) (0)
IN64-FR-01 From migraine genes to migraine triggering mechanisms and prophylaxis (2009) (0)
GENETIC AND HOR MONAL REGUL ATION OF SPRE ADING DEPRESSION (2016) (0)
Search for germline mutations by DGGE in Italian von Hippel-Lindau patients. (2001) (0)
4760 Elevated glutamate levels in the visual cortex of patients with Migraine detected at 7 Tesla (2013) (0)
Molecular Genetic Variants Associated with AMD in Italian Patients (2011) (0)
Redundancy of Accessory Subunits of CaV2.1 Channels in Transmitter Release at the Mouse Neuromuscular Junction (2007) (0)
EHMTI-0262. Dysregulation of inflammatory pathways in a familial hemiplegic migraine 1 mouse model after the induction of cortical spreading depression (2014) (0)
LackofAsymmetry ofMiddleCerebral Artery BloodVelocit inUnilateral Migraine (2013) (0)
Medication overuse in patients with chronic frequent headache in the general population (2008) (0)
Genome-wide association study for migraine in a Dutch genetic isolate and meta-analysis with other population-based cohorts (2011) (0)
W227 PROSPECTIVE EVALUATION OF POTENTIAL PREDICTIVE MARKERS OF PRE‐ECLAMPSIA ANALYZING MESSENGER RNAs CIRCULATING IN MATERNAL PLASMA (2012) (0)
Last-Minute Poster Presentations (2005) (0)
FHM1 S218L mutation associated with trauma triggered delayed cerebral coma and seizures in sporadic cases (2007) (0)
White Matter Damage in Pure and Complicated Hereditary Spastic Paraparesis (P03.164) (2012) (0)
Treating Migraine Attacks ASAP: Concept and Methodological Issues (2006) (0)
The use of optogenetic stimulation for non-invasive induction of cortical spreading depression in anaesthetized and freely behaving mice (2015) (0)
Further considerations concerning non-invasive prenatal diagnosis of craniosynostosis based on the identification of an 18 bp deletion in the TWIST1 gene by COLD-PCR (2014) (0)
Introduction to Nanotechnology. Charles P. Poole, Jr., and Frank J. Owens. Hoboken, NJ: John Wiley & Sons, 2003, 400 pp., $79.95, hardcover. ISBN 0-471-07935-9. (2004) (0)
Meiotic recombination in the i globin gene cluster causing an error in prenatal diagnosis of f3 thalassaemia (2004) (0)
Which Are the best Tools for Specific Clinical Application (Chips, Multiplex, Mass Spec Profile, etc.)? (2003) (0)
Objectives of Biomarkers in Early Drug Development Biomarkers for Pharmacological Effects Biomarkers for (patho)physiological Principle Biomarkers for Therapeutic Principle Table 1 Number of Tests within Individual Domains Neuropsychological Domains Neuroleptics Selective Serotonin Re-uptake Inhibit (0)
functionof sex steroid hormones on cerebrovascular (2015) (0)
Increased Susceptibility to Hypoxic/ischemic Injury in FHM1 Mutant Mice (2015) (0)
Invited Speakers for Scientific Sessions (2005) (0)
Trigeminal autonomic cephalalgias characterized by similar structural differences in the anterior hypothalamus (2009) (0)
[Controversy surrounding the term 'retinal migraine']. (2010) (0)

This paper list is powered by the following services:

Other Resources About Michel Ferrari

en.wikipedia.org

What Schools Are Affiliated With Michel Ferrari?

Michel Ferrari is affiliated with the following schools:

Image Attributions

Image Source for Michel Ferrari